Lenalidomide in Combination With CHOP in Patients With Untreated PTCL

NCT04423926 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

91

Enrollment

OTHER

Sponsor class

Conditions

PTCL, NOS
AITL
ALK- ALCL
Phase III-IV ALK+ ALCL
EATL

Interventions

DRUG: Lenalidomide
DRUG: Cyclophosphamide
DRUG: Doxorubicin
DRUG: Vincristine
DRUG: Prednisolone

Sponsor

The First Affiliated Hospital with Nanjing Medical University